Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Overview

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. specializes in the realm of cardiovascular and cerebrovascular disease treatments through its commitment to the research, development, production, and sale of a wide array of heparin products. The company’s focus spans crude heparin, heparin raw materials, and heparin preparations. Operating not only within the borders of China but also on an international scale, it showcases Hebei Changshan's extensive reach in the pharmaceutical industry. Founded in the year 2000 and situated in Shijiazhuang, China, the company has established itself as a significant player in the pharmaceutical market, underlining its expertise in heparin-based products.

Products and Services

• Crude Heparin Sodium: This is the foundational substance used for creating various heparin products. It is derived from porcine intestinal mucosa and serves as the raw material for further refinement and production.
• Heparin Sodium Raw Materials: These are processed from crude heparin sodium to meet specific pharmaceutical grades, ensuring quality and efficacy for further manufacturing into finished products.
• Heparin Sodium Injections: A finished pharmaceutical preparation of heparin sodium used for anticoagulation to prevent and treat thrombosis and embolism.
• Low Molecular Weight Heparin Calcium Raw Materials and Injections: These products involve further processing of heparin to reduce its molecular weight, enhancing its bioavailability and anticoagulant properties, used in the form of injections.
• Enoxaparin Sodium Raw Materials and Injections: Enoxaparin is a form of low molecular weight heparin particularly used for the prevention of deep vein thrombosis (DVT) and treatment of acute coronary syndrome. The company supplies both the raw materials and the ready-to-use injections.
• Nadroparin Calcium API: This active pharmaceutical ingredient (API) refers to another low molecular weight heparin used for similar indications as enoxaparin and is a critical component in manufacturing nadroparin calcium injections.
• Nadroparin Calcium Injection: A finished pharmaceutical product used primarily for the prevention of DVT and treatment of venous thromboembolism.
• Dalteparin Sodium API and Injection: Dalteparin sodium, another variant of low molecular weight heparin, is targeted for similar uses but may vary in its pharmacological profile. The company provides both the API for formulation and the final injectable product.